Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SuperGen down on Orathecin data

SUPG was off $0.93 (18%) to $4.10 on

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE